GleamWall
中文EN

BTMD biote Corp.

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1819253 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-8.6%
TTM net income YoY-106.7%
TTM EPS YoY-108.9%
Revenue 3-yr CAGR-1.0%
Net income 3-yr CAGR—

Margins

Gross margin67.5%
Operating margin5.0%
Net margin-1.1%
FCF margin4.1%
EBITDA margin6.6%

Returns

ROE—
ROA-1.8%
ROIC (approx.)18.5%
Asset turnover1.68x

Leverage & solvency

Liabilities / assets156.6%
Debt / equity—
Current ratio1.37x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-7.26x
Accruals ratio-14.9%
Payout ratio—
Capex / revenue3.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$192.22M$197.19M
Cost of revenue$54.86M$58.13M
Gross profit$137.36M$139.06M
SG&A expense$101.81M$107.45M
Operating income$35.55M$31.61M
Pretax income$37.58M$1.02M
Income tax$5.99M$970,000
Net income$27.05M$3.16M
EBITDA$39.22M$35.19M
EPS (basic)0.860.09
EPS (diluted)0.740.09
Weighted avg. shares (diluted)36.67M34.27M
Balance sheet
Cash & equivalents$24.12M$39.34M
Receivables$6.87M$7.63M
Inventory$19.06M$14.85M
Current assets$54.67M$68.13M
PP&E, net$10.75M$6.97M
Goodwill$5.83M$5.83M
Intangibles$4.27M$5.50M
Total assets$107.61M$122.37M
Current liabilities$44.99M$51.51M
Short-term debt$6.25M$6.25M
Long-term debt$95.78M$101.20M
Total debt$102.03M$107.45M
Total liabilities$158.01M$224.57M
Shareholders' equity-$58.54M-$105.93M
Net debt$77.91M$68.11M
Cash flow statement
Operating cash flow$35.19M$45.24M
Capital expenditure$5.01M$6.43M
Free cash flow$30.18M$38.81M
Investing cash flow-$6.86M-$18.80M
Financing cash flow-$43.55M-$76.08M
Depreciation & amortization$3.67M$3.57M
Stock-based compensation$8.92M$8.73M
Dividends paid$1.73M$4.74M
Share buybacks$3.37M$5.60M

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.